文献速递免疫规划

HLA-DPA1与DPB1共同决定乙肝疫苗应答

Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1.
PubMed 文献 · Vaccine · 2019-09-09

研究纳入152例加强免疫后抗-HBs不可测青少年为病例,207例16岁时抗-HBs≥10 mIU/mL及481例加强后抗-HBs≥1.0 mIU/mL者为对照,采用序列分型检测HLA-DPA1和DPB1基因型。结果显示两基因保护性等位基因共同存在时抗-HBs不可测风险显著降低,调整OR(95%CI)为0.122(0.058-0.257),且存在基因-基因交互作用。

要点

  • HLA-DPA1*01:03:01与较低的抗-HBs不可测风险相关
  • DPA1与DPB1保护性等位基因同时存在时风险最低,调整OR=0.122
  • 携带特定氨基酸多态性组合者风险升高4.3至4.6倍

核心结论

  • HLA-DPA1和DPB1基因共同影响婴儿期乙肝疫苗基础免疫后免疫应答的持久性。
  • HLA-DP风险等位基因的效应受保护性等位基因主导,且存在显著的基因-基因交互作用。

研究设计与样本

  • 病例对照研究,病例为152例加强免疫后抗-HBs不可测(<1.0 mIU/mL)的青少年。
  • 对照为207例16岁时抗-HBs≥10 mIU/mL者及481例加强后抗-HBs≥1.0 mIU/mL者。
  • HLA-DPA1和DPB1基因型通过序列分型确定。

主要发现

  • HLA-DPA1*01:03:01与较低的抗-HBs不可测OR相关,DPA1*02:02:02和DPB1*05:01:01与较高的OR相关。
  • HLA-DPA1*01:03:01-DPB1*05:01:01及DPA1*02:02:02-DPB1*保护性组合类型的OR显著小于1.0。
  • 与无保护性等位基因者相比,仅DPA1有保护性等位基因者调整OR(95%CI)为0.545(0.328-0.906)。
  • 仅DPB1有保护性等位基因者调整OR(95%CI)为0.350(0.174-0.702),两基因均有者为0.122(0.058-0.257)。
  • 携带Arg81-Pro158-Val191-Pro259α+Met234β和Gln62-Arg82α+Met234β组合者风险为4.3至4.6倍。

临床怎么用

  • 检测HLA-DPA1和DPB1保护性等位基因有助于识别乙肝疫苗免疫应答持久性较低者。
  • 研究结果为设计更有效的乙肝疫苗提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: No report explored the combined effects of HLA-DPA1 and -DPB1 with long-term response to hepatitis B (HB) vaccination (HBVac). The specific aims of the study were to assess the combined effects and relative contributions of DPA1 and DPB1 genes. METHODS: The cases were 152 adolescents who had undetectable (<1.0 mIU/mL) post-booster anti-HBs titers and the controls were adolescents who had residual anti-HBs ≥ 10 mIU/mL at aged 16 years (n = 207) or had detectable (≥1.0 mIU/mL) anti-HBs titers after booster HBVac (n = 481). HLA-DPA1 and -DPB1 genotypes were determined by sequence-based typing. RESULTS: HLA-DPA1*01:03:01 was correlated with lower ORs of undetectable anti-HBs titers, while -DPA1*02:02:02 and -DPB1*05:01:01 were correlated with higher ORs. The ORs for HLA-DPA1*01:03:01-DPB1*05:01:01 and DPA1*02:02:02-DPB1*protective combinatory types were significantly less than 1.0. As compared with subjects who had no protective allele, the adjusted ORs (95% CI) were 0.545 (0.328-0.906), 0.350 (0.174-0.702), and 0.122 (0.058-0.257), for subjects who had protective alleles on DPA1only, DPB1 only, and both genes, respectively. Analyses of amino acid polymorphisms showed that subjects who carried Arg81-Pro158-Val191-Pro259α + Met234β and Gln62-Arg82α + Met234β combinations had 4.3-to-4.6 folds of risks. CONCLUSION: Both DPA1 and DPB1 genes contribute to the persistence of immunological response to primary infantile HBVac. The effects of HLA-DP risk alleles were dominated by the protective alleles and there were significant gene-gene interactions. Our findings provide evidences for the design of more potent HB vaccine.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wang LY, Chen CF, Wu TW, et al. Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1. Vaccine. 2019. PMID: 31515149. doi:10.1016/j.vaccine.2019.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。